A maker of biomedical filters will invest $243 million to build a plant in Athens, Georgia, that is projected to eventually employ nearly 1,800 workers by 2031.
Privately held Meissner Corp. of Camarillo, California, made the announcement Wednesday, saying it needs another site to make filters and conduct research. President Christopher Meissner said in a statement that the Georgia location offers “an incredible talent pool and strong geographic position that allows us to serve clients on the East Coast and throughout the world.”
The company’s products are used to develop and manufacture medicines to treat cancer, heart disease, immune diseases and other illnesses. Meissner said its products were used to make vaccines to immunize against COVID-19 and drugs to treat the respiratory illness.
Read this story for free
To continue reading, sign up for our newsletters and get unlimited access to WABE.org
We won't share your information with outside organizations Why am I seeing this?
